MUMBAI: New Delhi-based Morepen LaboratoriesBSE 8.27 % is in talks with Ajay Piramal Group to sell its OTC (over-the-counter) business of market leading brands such as Burnol as it plans to monetise some of its...
Zydus Cadila partners Takeda for chikungunya vaccine
NEW DELHI: Japanese pharmaceutical giant Takeda Pharmaceutical has entered into a partnership with Ahmedabad-based ZydusBSE 0.14 % Cadila to develop the first ever vaccine to tackle Chikungunya, an emerging infectious...
CCI clears Piramal Enterprises-Pfizer deal
NEW DELHI: Fair trade regulator CCI has approved Ajay Piramal-led Piramal Enterprises’ proposed acquisition of four brands from pharmaceutical major Pfizer. As per the deal announced in May, Piramal...
China Resources Sanjiu completes full acquisition of Shenghuo Pharma
China Resources Sanjiu Co Ltd : * Says it completes full acquisition of 100 percent stake in Kunming Shenghuo Pharmaceutical Group Co Ltd * Plan was disclosed on July 26 Source text in Chinese: goo.gl/IiEzJU Further...
Glenmark announces tie up for anti cancer drug
Drug maker Glenmark has signed up with US-based research organization Particle Sciences Inc to develop and distribute a generic version of an anti-cancer injectable ‘Abraxane’ giving a boost to its oncology...
PE majors initiate talks to acquire diagnostics chain Medall Healthcare
MUMBAI: Global buyout funds Apax Partners, Bain Capital, Barings Asia, Carlyle, and KKR are in initial talks to acquire 100% stake in diagnostics services provider Medall Healthcare. Medall Healthcare’s top...
Lupin says looking at buyout opportunities in domestic market
Mumbai: After a series of acquisitions in overseas markets over the past two years, Lupin Ltd is looking at buyout opportunities in the domestic market to gain market share, said a top executive. These could be either...
Fosun Pharma looks to digest India’s Gland, eyes other markets
SHANGHAI: Chinese drugmaker Shanghai Fosun Pharmaceutical Group Co Ltd already has one eye on investments in other overseas markets after it announced a nearly $1.3 billion deal in July to India’s Gland Pharma...
Sanofi, Google launch diabetes joint venture
Google and French pharmaceutical giant Sanofi announced on Monday a new joint venture focused on diabetes care. The tie-up between the drug maker and Verily, the health subsidiary of Google’s parent company...
Serum hunts for acquisitions
The chief executive officer of Asia’s largest vaccine maker said he will consider selling a stake to private equity investors as he hunts for acquisitions in preparation for a bout of consolidation to hit the...
Indian Billionaire’s Vaccine Maker Hunts for Acquisitions
The chief executive officer of Asia’s largest vaccine maker said he will consider selling a stake to private equity investors as he hunts for acquisitions in preparation for a bout of consolidation to hit the industry...
Bayer shareholder says opposes new Monsanto takeover terms
A leading shareholder in German pharmaceutical and crops manufacturer Bayer said he did not support the revised terms of a takeover offer for U.S. rival Monsanto. John Bennett, the fund manager at Henderson, which had...
